2020 annual financial data
Recursion Pharmaceuticals 2020 Operating margin
Direct answer
Operating margin was -2,479.2%.
Operating income was -84,615,000 USD and net income was -87,006,000 USD.
Operating cash flow was -45,399,000 USD.
Get free Recursion Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,413,000 USD
- Operating income
- -84,615,000 USD
- Net income
- -87,006,000 USD
- Operating cash flow
- -45,399,000 USD